Impact of BMI and Comorbidities on the Efficacy of Once-Weekly Semaglutide
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Obesity
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial
Obesity 2023 Mar 06;[EPub Ahead of Print], BM McGowan, A Houshmand-Oeregaard, PN Laursen, N Zeuthen, J Baker-KnightFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.